Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)

NCT07733674 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma Multiforme (GBM)
Pancreatic Ductal Adenocarcinoma (PDAC)

Interventions

DRUG: 203Pb-RMX-VHPIB injection
DIAGNOSTIC_TEST: SPECT/CT Imaging

Sponsor

Radiomedix, Inc.